XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2022   18,730,380    
Beginning balance at Dec. 31, 2022 $ 562,147 $ 226,592 $ 435,085 $ (99,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (24,089)   (24,089)  
Share-based compensation expense 2,696 $ 2,696    
Common stock issued - Stock grants (in shares)   76,744    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (27,488)     (27,488)
Dividends declared on common stock (10,463)   (10,463)  
Common stock repurchased (in shares)   (13,094)    
Common stock repurchased (316) $ (316)    
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2023   18,794,030    
Ending balance at Sep. 30, 2023 502,487 $ 228,972 400,533 (127,018)
Common stock shares outstanding, beginning balance (in shares) at Jun. 30, 2023   18,776,597    
Beginning balance at Jun. 30, 2023 527,623 $ 228,260 400,132 (100,769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 2,295   2,295  
Share-based compensation expense 712 $ 712    
Common stock issued - Stock grants (in shares)   17,433    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (26,249)     (26,249)
Dividends declared on common stock (1,894)   (1,894)  
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2023   18,794,030    
Ending balance at Sep. 30, 2023 $ 502,487 $ 228,972 400,533 (127,018)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2023 18,810,055 18,810,055    
Beginning balance at Dec. 31, 2023 $ 538,387 $ 229,889 395,357 (86,859)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (21,017)   (21,017)  
Share-based compensation expense 2,890 $ 2,890    
Common stock issued - Stock grants (in shares)   60,483    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) 18,189     18,189
Common stock repurchased (in shares)   (12,973)    
Common stock repurchased $ (134) $ (134)    
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2024 18,857,565 18,857,565    
Ending balance at Sep. 30, 2024 $ 538,315 $ 232,645 374,340 (68,670)
Common stock shares outstanding, beginning balance (in shares) at Jun. 30, 2024   18,857,565    
Beginning balance at Jun. 30, 2024 520,117 $ 231,721 381,622 (93,226)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (7,282)   (7,282)  
Share-based compensation expense 924 $ 924    
Other comprehensive income (loss) $ 24,556     24,556
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2024 18,857,565 18,857,565    
Ending balance at Sep. 30, 2024 $ 538,315 $ 232,645 $ 374,340 $ (68,670)